Syneos Health Appoints Rajneesh Patil to Lead AI and Innovation for Clinical Development

Syneos Health has appointed Rajneesh Patil as Head of AI and Innovation, Clinical Development, the company announced on 4th August. The appointment comes as the contract research organization continues expanding its use of artificial intelligence across clinical development and commercialization.

Syneos Health is a US based biopharmaceutical solutions company that provides clinical development, commercialization and consulting services to pharmaceutical and biotechnology companies. According to the company, it applies artificial intelligence and machine learning throughout the drug development lifecycle, including AI-driven patient recruitment, protocol optimization, predictive analytics for trial planning and commercial launch support.

Patil has led clinical technology and digital transformation initiatives throughout his career. Syneos Health said he has developed agentic AI solutions and holds 16 patents spanning the clinical trial lifecycle.

In his new role, he will lead the development of AI capabilities that help sponsors improve trial execution, navigate operational complexity and accelerate the delivery of new therapies.